Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE.
Monica M PurmalekPhilip M CarlucciAmit K DeyMaureen SampsonYenealem Temesgen-OyelakinSimantini SakhardandeJoseph B LermanAlice FikeMichael DavisJonathan H ChungTaufiq SalahuddinZerai MannaSarthak GuptaMarcus Y ChenSarfaraz HasniNehal N MehtaAlan RemaleyMariana J KaplanPublished in: Lupus science & medicine (2019)
Patients with SLE display a proatherogenic lipoprotein profile that may significantly contribute to the development of premature CVD. The results demonstrate that NMR measures of GlycA and lipoprotein profiles, beyond what is captured in routine clinical labs, could be a useful tool in assessing CVD risk in patients with SLE.